The expression of VEGF-C (and to a lesser extent that of VEGF-D) has been shown to correlate strongly with the risk of lymph node metastasis in over 30 studies of different malignancies, including lung, breast and colon cancers [2–4]. The gene discussed is VEGFC; the disease is metastatic malignant neoplasm in the lymph nodes.